Fund HoldingsSarissa Capital Management LP

Total Portfolio Value
$177.88M
Total Bought
$4.11M
Total Sold
$6.72M
Net Transaction
-$2.61M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
IRONWOOD PHARMACEUTICALS INC9,188,6359,188,635032,25238,68421.75%+6,432
LANTHEUS HLDGS INC(LNTH)166,919166,919012,66118,51810.41%+5,857
CYTOKINETICS INC(CYTK)228,623228,623015,06919,47610.95%+4,408
NEUROCRINE BIOSCIENCES INC(NBIX)116,533116,533015,35219,64011.04%+4,288
BIOHAVEN LTD(BHVN)563,184582,312+19,1284,7658,6654.87%+3,900
AMARIN CORP PLC1,673,3951,673,395024,19726,67415.00%+2,477
BIOGEN INC(BIIB)0950+95002050.12%+205
VOR BIOPHARMA INC(VOR)25,39925,39904534680.26%+14
REGENERON PHARMACEUTICALS(REGN)4,1904,19003,2372,6131.47%-625
INNOVIVA INC(INVA)2,130,9501,890,604-240,34649,65142,93624.14%-6,716
Page 1 of 1